Vanda Pharmaceuticals

Type: Company
Name: Vanda Pharmaceuticals
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Vanda Pharmaceuticals Makes a Move: Up 1.8%

One of today's stocks on the move is Vanda Pharmaceuticals (NASDAQ:VNDA), up 1.8% to $10.76. The S&P is trading fractionally lower to 1,976 and the Dow is trading fractionally higher to 17, ... [Published Individual.com - 2 hours ago]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Vanda Pharmaceuticals Shares Down 12.8% Since SmarTrend's Sell Call (VNDA)

SmarTrend identified a Downtrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on August 8th, 2014 at $12.33. In approximately 2 months, Vanda Pharmaceuticals has returned 12.78% as of today's recent price of $1 ... [Published Individual.com - Sep 26 2014]
First reported Sep 18 2014 - Updated Sep 19 2014 - 1 reports

53 http://www.biwahamistudio.com/welcome.htmdz fdsfsdfds

Since the 2008 Olympics in Beijing, where Acupuncture was given to the athletes and officials in the Olympic Village, Acupuncture has become increasingly more popular in the United States. While it has been used for thousands of years and is a main source ... [Published Student Village - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 2 reports

SAGE Therapeutics elects Michael F. Cola to board

Biopharmaceutical company SAGE Therapeutics (NasdaqGM:SAGE) disclosed on Tuesday the addition of Michael F. Cola to its board of directors. Currently, Cola serves as president and chief executive officer of Medgenics, a member of the board of directors ... [Published Individual.com - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Shares of Vanda Pharmaceuticals Under Pressure, Down 3.2%

One of today's stocks on the move is Vanda Pharmaceuticals (NASDAQ:VNDA), down 3.2% to $11.50. The Dow is up 0.6% to 17,131 and the S&P is currently up 0.7% to 1,998. ... [Published Individual.com - Sep 16 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 1 reports

NPD, TNK, VNDA, GJT, CHSCP, TLP Are Seasonally Ripe To Go Down In the Next Five Weeks

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of China Nepstar Chain Drugstore Ltd (NYSE:NPD), Teekay Tankers Ltd (NYSE:TNK), Vanda Pharmaceuticals Inc (NASDAQ:VNDA), Synthetic FixedIncome Securities Inc. Floating Rate Structured Repackaged ... [Published Individual.com - Sep 09 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Shares of Vanda Pharmaceuticals Under Pr...

Vanda Pharmaceuticals (NASDAQ:VNDA), a company whose shares are moving quickly, is trading 2.9% lower to $12.52. The S&P is trading fractionally lower to 1,998 and the Dow is trading fractionally lower to 17,090.Vanda Pharmaceuticals has overhead space ... [Published Financial News Network online - Aug 28 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

Vanda Pharmaceuticals Reports Second Quarter 2014 Results

WASHINGTON, Aug. 7, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced ... [Published PR Newswire: Financial Services - Aug 07 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014

WASHINGTON, July 17, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced ... [Published PR Newswire: Health - Jul 18 2014]
First reported Jun 04 2014 - Updated Jun 04 2014 - 1 reports

Why Vanda Pharmaceuticals (VNDA) Stock Is Surging Today

NEW YORK (TheStreet) -- Vanda Pharmaceuticals  surged Wednesday after the European Medicines Agency accepted the company's Marketing Authorization Application for Hetlioz, or tasimelteon, a medication that treats non-24-hour sleep-wake disorder. The ... [Published The Street Latest - Jun 04 2014]
First reported Jun 03 2014 - Updated Jun 03 2014 - 2 reports

European Medicines Agency Accepts HETLIOZ™ (tasimelteon) Marketing Authorization Application for Non-24-Hour Sleep-Wake Disorder in the Totally Blind

WASHINGTON, June 3, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today that its Marketing Authorization Application (MAA) for oral HETLIOZ™ (tasimelteon) capsules has been accepted for evaluation by the European Medicines ... [Published PR Newswire: Health - Jun 03 2014]
First reported May 30 2014 - Updated May 30 2014 - 1 reports

Vanda Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference

WASHINGTON, May 29, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced ... [Published PR Newswire: General Business - May 30 2014]

Quotes

"The idea is to redefine what inspires you. The idea is that I've gotten to this space is because I've had a lot of muses in my life [like Pablo Picasso and Leonardo Da Vinci]. People  timberland nellie boots that I look up to and draw inspiration from like how they prepare and how they focus on their particular field because the common denominator is the attention to detail, the hard work, the relentlessness."
"It's an honor to join SAGE Therapeutics at such an important time," said Mr. Cola. "With a successful IPO and the rapid development of its lead compound, SAGE-547, the company is poised to deliver new treatments for patients suffering from CNS disorders with few or no treatment options. I look forward to partnering with the SAGE team to expand and develop these efforts."
...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
...I'm starting to see a lot of talk about the potential head-and-shoulders top that's forming on the Nasdaq 100 Index (NDX)," continued Sapp. "Generally, whenever mainstream media picks up on chart patterns like this, it's a contrarian signal. I would closely monitor the amount of talk there is regarding this formation, as a consensus 'top formation' sentiment among market participants would likely be a signal to take the other side and play technology bullishly."

More Content

All (42) | News (16) | Reports (0) | Blogs (21) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
Vanda Pharmaceuticals Makes a Move: Up 1.8% [Published Individual.com - 2 hours ago]
Vanda Pharmaceuticals Shares Down 12.8% Since S... [Published Individual.com - Sep 26 2014]
53 http://www.biwahamistudio.com/welcome.htmdz ... [Published Student Village - Sep 18 2014]
Leading Health Care Stock for Small-Cap Stars i... [Published Equities.com - Sep 17 2014]
SAGE Therapeutics elects Michael F. Cola to board [Published Individual.com - Sep 17 2014]
Shares of Vanda Pharmaceuticals Under Pressure,... [Published Individual.com - Sep 16 2014]
SAGE Therapeutics Appoints Michael F. Cola to t... [Published EMoneyDaily - Sep 16 2014]
NPD, TNK, VNDA, GJT, CHSCP, TLP Are Seasonally ... [Published Individual.com - Sep 09 2014]
Shares of Vanda Pharmaceuticals Under Pr... [Published Financial News Network online - Aug 28 2014]
Expert Briefing on Biotech Stocks -- Nanosphere... [Published Financial Services - Aug 14 2014]
Vanda Pharmaceuticals Reports Second Quarter 20... [Published PR Newswire: Financial Services - Aug 07 2014]
Vanda Pharmaceuticals to Announce Second Quarte... [Published PR Newswire: Health - Jul 18 2014]
New Patents, Clinical Trial Updates, New Agreem... [Published Financial Services - Jun 26 2014]
Morning Analysis on Top Gainers -- Research on ... [Published Financial Services - Jun 05 2014]
Stocks: New High for the S&P 500; Under Armour ... [Published BARRONS.com Stocks To Watch Today - Jun 04 2014]
Why Vanda Pharmaceuticals (VNDA) Stock Is Surgi... [Published The Street Latest - Jun 04 2014]
EMA accepts Vanda's marketing application for N... [Published PBR - News - Jun 04 2014]
European Medicines Agency Accepts HETLIOZ™ (tas... [Published PR Newswire: Health - Jun 03 2014]
HETLIOZ™ (tasimelteon) Data in Patients with No... [Published PR Newswire: General Business - Jun 03 2014]
Vanda Pharmaceuticals to Present at the Jefferi... [Published PR Newswire: General Business - May 30 2014]
Clinical Trial Updates, Leadership Appointments... [Published PR Newswire: Financial Services - May 15 2014]
Forget Rent: The Cost of These 5 New Drugs Is T... [Published Wall St. Cheat Sheet - May 13 2014]
Biotech Stocks on our Radar -- Research on Immu... [Published Financial Services - May 09 2014]
Biggest Movers: hhgregg, Inc., GT Advanced Tech... [Published Schaeffers Research - May 08 2014]
Dow Jones Industrial Average Marches Higher; Ye... [Published Schaeffers Research - May 08 2014]
Vanda Pharmaceuticals Reports First Quarter 201... [Published PR Newswire: Financial Services - May 08 2014]
Released and Scheduled Earnings Results - Analy... [Published PR Newswire: Financial Services - May 06 2014]
Vanda Pharmaceuticals to Announce First Quarter... [Published PR Newswire: Health - Apr 24 2014]
Vanda Pharma introduces Hetlioz in US market to... [Published PharmaBiz - Apr 11 2014]
Biotech Stocks Technical Data -- Research on Ce... [Published Financial Services - Apr 10 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Vanda Pharmaceuticals Reports Second Quarter 20... [Published PR Newswire: Financial Services - Aug 07 2014]
WASHINGTON, Aug. 7, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced ...
Vanda Pharmaceuticals to Announce Second Quarte... [Published PR Newswire: Health - Jul 18 2014]
WASHINGTON, July 17, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced ...
Stocks: New High for the S&P 500; Under Armour ... [Published BARRONS.com Stocks To Watch Today - Jun 04 2014]
It was the night before the ECB–and two before US payrolls–and all through the market nothing was stirring, not even…Alright. Some things were stirring, like the shares of Protective Life (PL), Travelers Companies (TRV), Under Armour (UA), Broadcom (BRCM) ...
EMA accepts Vanda's marketing application for N... [Published PBR - News - Jun 04 2014]
The European Medicines Agency (EMA) has accepted to evaluate Vanda Pharmaceuticals' Marketing Authorization Application (MAA) for oral HETLIOZ (tasimelteon) capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). ...
European Medicines Agency Accepts HETLIOZ™ (tas... [Published PR Newswire: Health - Jun 03 2014]
WASHINGTON, June 3, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today that its Marketing Authorization Application (MAA) for oral HETLIOZ™ (tasimelteon) capsules has been accepted for evaluation by the European Medicines ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Expert Briefing on Biotech Stocks -- Nanosphere... [Published Financial Services - Aug 14 2014]
New Patents, Clinical Trial Updates, New Agreem... [Published Financial Services - Jun 26 2014]
Morning Analysis on Top Gainers -- Research on ... [Published Financial Services - Jun 05 2014]
Biotech Stocks on our Radar -- Research on Immu... [Published Financial Services - May 09 2014]
Biotech Stocks Technical Data -- Research on Ce... [Published Financial Services - Apr 10 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.